When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Hiperparatireoidismo primário

Última revisión: 3 Feb 2026
Última actualización: 19 Nov 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • achado incidental em testes bioquímicos
  • história de osteoporose ou osteopenia
  • história familiar de hiperparatireoidismo ou características sugestivas de hipercalcemia
  • nefrolitíase
Todos los datos

Otros factores de diagnóstico

  • má qualidade do sono
  • fadiga
  • mialgia
  • ansiedade
  • depressão
  • perda de memória
  • disfunção neuromuscular evidente
  • disfunção cardiovascular e metabólica
  • sintomas gastrointestinais
Todos los datos

Factores de riesgo

  • sexo feminino
  • idade ≥50-60 anos
  • neoplasia endócrina múltipla (NEM) 1, 2A ou 4
  • histórico ou tratamento atual com lítio
  • síndrome do tumor mandibular hiperparatireoidiano
  • história familiar de HPTP
  • história de irradiação da cabeça e do pescoço
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • cálcio sérico
  • paratormônio (PTH) intacto sérico com ensaio imunorradiométrico ou imunoquímico
Todos los datos

Pruebas diagnósticas que deben considerarse

  • nível da 25-hidroxivitamina D
  • fosfatase alcalina sérica
  • fósforo sérico
  • cálcio urinário de 24 horas
  • exame de absorciometria por dupla emissão de raios X (DEXA)
  • escore ósseo trabecular
  • ultrassonografia do pescoço
  • cintilografia com tecnécio-99m sestamibi
  • TC por emissão de fóton único (SPECT)
  • tomografia computadorizada (TC) do pescoço
  • TC quadridimensional (4D) de pescoço
  • ressonância nuclear magnética (RNM) do pescoço
Todos los datos

Pruebas emergentes

  • PET com colina radiomarcada
  • aprendizado de máquina para identificar hiperparatireoidismo primário

Algoritmo de tratamiento

En curso

assintomático sem indicações cirúrgicas ou sintomático

assintomático sem indicações cirúrgicas

Colaboradores

Autores

John Ayuk, MD

Consultant Endocrinologist

University Hospitals Birmingham

Birmingham

UK

Disclosures

JA declares that he has no competing interests.

Neil Gittoes, MD, PhD

Consultant Endocrinologist and Honorary Professor of Endocrinology

Associate Medical Director

University Hospitals Birmingham

Birmingham

UK

Disclosures

NG is an author of several references cited in this topic and is a member of the 2021 European Society of Endocrinology Educational Program of Parathyroid Disorders (PARAT) Working Group.

Acknowledgements

Dr John Ayuk and Professor Neil Gittoes would like to gratefully acknowledge Dr Fausto Palazzo, Dr Swaroop Gantela, and Dr Nancy D. Perrier, the previous contributors to this topic. FP, SG, and NDP declare that they have no competing interests.

Peer reviewers

Brendan C. Stack Jr, MD, FACS, FACE

Chairman, Endocrine Surgery Section

American Head and Neck Society

Professor and former inaugural Chairman

Department of Otolaryngology-Head and Neck Surgery

Southern Illinois University School of Medicine

Springfield

IL

Раскрытие информации

BCS declares that he has no competing interests.

Petros Perros, BSc, MBBS, MD, FRCP

Department of Endocrinology

Elliott Building

Royal Victoria Infirmary

Newcastle-upon-Tyne

UK

Раскрытие информации

PP declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth International Workshop. J Bone Miner Res. 2022 Nov;37(11):2293-314.Полный текст  Аннотация

Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.Полный текст  Аннотация

Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol. 2022 Feb 1;186(2):R33-63.Полный текст  Аннотация

Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018 Feb;14(2):115-25.Полный текст  Аннотация

Petranović Ovčariček P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности